OraSure Technologies, Inc. completed the acquisition of Novosanis NV.
January 04, 2019
Share
OraSure Technologies, Inc. (NasdaqGS:OSUR) entered into a definitive agreement to acquire Novosanis NV on January 4, 2019. The transaction is structured with an upfront cash payment and potential additional payments based on future performance. In a related transaction, OraSure entered into an agreement to acquire CoreBiome, Inc. for The transaction is expected to close within the next week. OraSure expects that the acquisitions will together contribute from $4 million to $7 million in net revenues in 2019, with $0.03 to $0.05 per share of dilution to non-GAAP earnings excluding transaction costs and required acquisition accounting adjustments. Vincent Dirckx, Carl Leermakers, Benoît Vandervelde, Guillaume Beauthier and Philippe Hendrickx of CMS Belgium acted as legal advisors for OraSure Technologies.
OraSure Technologies, Inc. (NasdaqGS:OSUR) completed the acquisition of Novosanis NV on January 5, 2019. Novosanis NV will operate as a wholly owned subsidiary of OraSure Technologies Inc. The OraSure Technologies acquired Novosanis NV and CoreBiome, Inc for combined deal value of $13.3 million.
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
ORASURE TECHNOLOGIES, INC. 
